/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ TSXV: FIRE TORONTO, Nov. 14, 2017 /CNW/ - Supreme Pharmaceuticals Inc. (`Supreme` or the `Company`) (TSXV:FIRE) is pleased to announce the closing of its previously announced bought deal private placement of 40,250 convertible debenture units (the `Convertible Debenture Units`), including the exercise of the Underwriters` over-allotment option (the `Offering`), with a syndicate of underwriters, led by Canaccord Genuity Corp., including Beacon Securities Limited, Cormark Securities Inc., Eight Capital, GMP Securities L.P., and PI Financial Corp., for gross proceeds of approximately $40.25 million. Each Convertible...
|
